Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

Y. Xiao, F. Yin, Feng Ming Kong, J. Yue, J. Galvin

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

Original languageEnglish (US)
Title of host publicationWorld Congress on Medical Physics and Biomedical Engineering
Pages2284-2287
Number of pages4
DOIs
StatePublished - Apr 16 2013
EventWorld Congress on Medical Physics and Biomedical Engineering - Beijing, China
Duration: May 26 2012May 31 2012

Publication series

NameIFMBE Proceedings
Volume39 IFMBE
ISSN (Print)1680-0737

Other

OtherWorld Congress on Medical Physics and Biomedical Engineering
CountryChina
CityBeijing
Period5/26/125/31/12

Keywords

  • NSCLC
  • SBRT
  • Surgery
  • clinical trials
  • quality

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials'. Together they form a unique fingerprint.

  • Cite this

    Xiao, Y., Yin, F., Kong, F. M., Yue, J., & Galvin, J. (2013). Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. In World Congress on Medical Physics and Biomedical Engineering (pp. 2284-2287). (IFMBE Proceedings; Vol. 39 IFMBE). https://doi.org/10.1007/978-3-642-29305-4_599